Changes of HbA1c variability after the switch to a longer‐acting insulin analog in people with type 1 diabetes

This study investigated whether longer‐acting basal analogs (insulin degludec and insulin glargine U300) could reduce visit‐to‐visit hemoglobin A1c (HbA1c) variability in patients with type 1 diabetes. Ninety adults with type 1 diabetes for whom the basal insulin was switched to a longer‐acting insu...

Descripción completa

Detalles Bibliográficos
Autores principales: Watanabe, Hirotaka, Takahara, Mitsuyoshi, Katakami, Naoto, Shimomura, Iichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9889620/
https://www.ncbi.nlm.nih.gov/pubmed/36345602
http://dx.doi.org/10.1111/jdi.13941

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9889620/
https://www.ncbi.nlm.nih.gov/pubmed/36345602
http://dx.doi.org/10.1111/jdi.13941

Ejemplares similares